SG10201401305SA - Methods of predicting cancer risk using gene expression in premalignant tissue - Google Patents

Methods of predicting cancer risk using gene expression in premalignant tissue

Info

Publication number
SG10201401305SA
SG10201401305SA SG10201401305SA SG10201401305SA SG10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA
Authority
SG
Singapore
Prior art keywords
methods
gene expression
cancer risk
predicting cancer
premalignant tissue
Prior art date
Application number
SG10201401305SA
Other languages
English (en)
Inventor
Wayne Cowens
Maureen T Cronin
Carl L Millward
François Collin
Michael Crager
Original Assignee
Genomic Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomic Health Inc filed Critical Genomic Health Inc
Publication of SG10201401305SA publication Critical patent/SG10201401305SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG10201401305SA 2009-04-07 2010-04-07 Methods of predicting cancer risk using gene expression in premalignant tissue SG10201401305SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16750309P 2009-04-07 2009-04-07
US24370809P 2009-09-18 2009-09-18

Publications (1)

Publication Number Publication Date
SG10201401305SA true SG10201401305SA (en) 2014-08-28

Family

ID=42936861

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2011070760A SG174611A1 (en) 2009-04-07 2010-04-07 Methods of predicting cancer risk using gene expression in premalignant tissue
SG10201401305SA SG10201401305SA (en) 2009-04-07 2010-04-07 Methods of predicting cancer risk using gene expression in premalignant tissue

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2011070760A SG174611A1 (en) 2009-04-07 2010-04-07 Methods of predicting cancer risk using gene expression in premalignant tissue

Country Status (8)

Country Link
US (1) US8765383B2 (fr)
EP (1) EP2417271A4 (fr)
AU (1) AU2010234456A1 (fr)
CA (1) CA2757927A1 (fr)
IL (1) IL215253A0 (fr)
NZ (1) NZ595356A (fr)
SG (2) SG174611A1 (fr)
WO (1) WO2010118166A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2412820A1 (fr) * 2006-01-11 2012-02-01 Genomic Health, Inc. Marqueurs de l'expression génique pour le pronostic du cancer colorectal
US8067178B2 (en) 2008-03-14 2011-11-29 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
US10179936B2 (en) * 2009-05-01 2019-01-15 Genomic Health, Inc. Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
WO2012015765A2 (fr) 2010-07-27 2012-02-02 Genomic Health, Inc. Procédé d'utilisation de l'expression génique pour déterminer le pronostic du cancer de la prostate
DK2809810T3 (da) * 2012-01-06 2020-02-03 Viomics Inc System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer
EP3739595A3 (fr) 2012-01-31 2021-01-27 Genomic Health, Inc. Algorithme de profil d'expression génique et test de détermination du pronostic du cancer de la prostate
CN105143882B (zh) * 2013-04-11 2018-10-26 塞托克尔公司 使用细胞学和免疫学的生物学样本评估方法
WO2015138889A1 (fr) * 2014-03-13 2015-09-17 The Penn State Research Foundation Compositions et méthodes de diagnostic de stades d'endobrachyoesophage
EP3169354A4 (fr) 2014-07-17 2018-06-13 Brian J. Czerniecki Identification de peptides immunogènes de classe ii du complexe majeur d'histocompatibilité pour une immunothérapie
EP3210144B1 (fr) 2014-10-24 2020-10-21 Koninklijke Philips N.V. Pronostic médical et prédiction de réponse de traitement utilisant de activités de voies de signalisation cellulaire multiples
AU2015334840B2 (en) 2014-10-24 2021-10-21 Innosign B.V. Assessment of TGF-beta cellular signaling pathway activity using mathematical modelling of target gene expression
JP7065609B6 (ja) 2014-10-24 2022-06-06 コーニンクレッカ フィリップス エヌ ヴェ 複数の細胞シグナル伝達経路活性を用いる治療応答の医学的予後及び予測
ITUB20150652A1 (it) * 2015-05-21 2016-11-21 Univ Bologna Alma Mater Studiorum Nuovo metodo diagnostico e kit
EP3325005A4 (fr) * 2015-07-17 2019-03-27 Brian J. Czerniecki Identification de peptides immunogènes de classe ii du complexe majeur d'histocompatibilité pour une immunothérapie
BR112018002848A2 (pt) 2015-08-14 2018-11-06 Koninklijke Philips Nv método, aparelho, mídia de armazenamento não transitório, programa de computador, kit para medir níveis de expressão de seis ou mais genes-alvo da via de sinalização celular
EP3461915A1 (fr) 2017-10-02 2019-04-03 Koninklijke Philips N.V. Évaluation de l'activité de la voie de signalisation cellulaire jak-stat1/2 faisant appel à une modélisation mathématique de l'expression du gène cible
EP3502279A1 (fr) 2017-12-20 2019-06-26 Koninklijke Philips N.V. Évaluation de l'activité de la voie de signalisation cellulaire mapk-ap 1 faisant appel à une modélisation mathématique de l'expression du gène cible

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953658B2 (en) 2000-03-09 2005-10-11 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
US7622260B2 (en) 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
US7955800B2 (en) 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
US20040053317A1 (en) 2002-09-10 2004-03-18 Sidney Kimmel Cancer Center Gene segregation and biological sample classification methods
WO2005076005A2 (fr) 2004-01-30 2005-08-18 Medizinische Universität Wien Procede de classification d'un prelevement de cellules tumorales
WO2006138275A2 (fr) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions et procedes de traitement et de diagnostic de cancer
WO2006135886A2 (fr) 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions et methodes pour le traitement et le diagnostic du cancer
JP2009505658A (ja) 2005-08-24 2009-02-12 ブリストル−マイヤーズ スクイブ カンパニー 上皮増殖因子受容体モデュレーターに対する感受性を決定するためのバイオマーカーおよび方法
EP2412820A1 (fr) 2006-01-11 2012-02-01 Genomic Health, Inc. Marqueurs de l'expression génique pour le pronostic du cancer colorectal
US7812143B2 (en) 2006-03-31 2010-10-12 Memorial Sloan-Kettering Cancer Center Biomarkers for cancer treatment
NZ562237A (en) 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
CA2723984A1 (fr) 2008-05-14 2009-11-19 Genomic Health Inc. Predicteurs de reponse de patient a un traitement avec des inhibiteurs des recepteurs de egf
CN102159729B (zh) * 2008-09-22 2015-07-15 怡发科技股份有限公司 肺癌及结肠直肠癌的分子标记

Also Published As

Publication number Publication date
AU2010234456A1 (en) 2011-10-20
SG174611A1 (en) 2011-11-28
EP2417271A2 (fr) 2012-02-15
US20100291573A1 (en) 2010-11-18
CA2757927A1 (fr) 2010-10-14
EP2417271A4 (fr) 2012-08-29
WO2010118166A2 (fr) 2010-10-14
IL215253A0 (en) 2011-12-29
NZ595356A (en) 2013-07-26
US8765383B2 (en) 2014-07-01
WO2010118166A3 (fr) 2011-03-17

Similar Documents

Publication Publication Date Title
IL215253A0 (en) Methods of predicting cancer risk using gene expression in premalignant tissue
IL276487B (en) Methods for predicting clinical outcome of cancer
IL280689B (en) A method for using gene expression to determine the likelihood of clinical outcome in kidney cancer
IL258794B (en) Methods and preparations for the diagnosis and treatment of cancer
EP2401357A4 (fr) Cellules hôtes et procédés d'utilisation
IL218575A0 (en) Treatment of cancer
HK1217763A1 (zh) 用於治療疾病的方法
IL216044A0 (en) Method of expanding human hepatocytes in vivo
IL214255A0 (en) Methods and compositions for diagnosis and treatment of cancer
EP2438197A4 (fr) Procédé de détection du cancer
EP2389573A4 (fr) Procédés d'analyse de la peau
EP2373794A4 (fr) Nectine-4 pour gènes cibles de thérapie contre le cancer et de diagnostic du cancer
EP2398901A4 (fr) Jarid1b en tant que gène cible d'un traitement anticancéreux et d'un diagnostic de cancer
EP2475790A4 (fr) Procédés et compositions pour prédire une réponse à une thérapie anticancéreuse
EP2467140A4 (fr) Procédé de traitement du cancer
EP2402053A4 (fr) Sonde électro-hydraulique de traitement du tissu prostatique
GB0908788D0 (en) Tissue analysis
EP2470903A4 (fr) Gène et polypeptide associés au cancer du sein
EP2384370A4 (fr) Utilisation de id4 pour le diagnostic et le traitement du cancer
GB0916686D0 (en) Treatment of cancer
EP2350276A4 (fr) Syngr4 pour gènes cibles du traitement et du diagnostic du cancer
EP2262541A4 (fr) C2orf18 comme gène cible d'une thérapie et d'un diagnostic du cancer
TWM371583U (en) Mashing structure of anvil block
GB0921757D0 (en) Treatment of cancer
GB0906490D0 (en) Use of tetanolic for treatment of breast cancer